Patient characteristics | IBC | Non-IBC | Healthy | |||
---|---|---|---|---|---|---|
N = 20 | (% ) | N = 20 | (%) | N = 20 | (%) | |
Age range | 34-70 | 29-78 | Â | 21-80 | ||
Mean age | 49.0 | 50.2 | Â | 45.5 | ||
Menopausal status | Â | Â | Â | Â | Â | Â |
Pre-menopausal | 10 | 50% | 10 | 50% | 10 | 50% |
Post-menopausal | 10 | 50% | 10 | 50% | 10 | 50% |
Histological grade | Â | Â | Â | Â | Â | Â |
I | 0 | 0% | 0 | 0% | Â | Â |
II | 9 | 45% | 7 | 35% | Â | Â |
III | 11 | 55% | 13 | 65% | Â | Â |
Node status | Â | Â | Â | Â | Â | Â |
N0 | 2 | 10% | 7 | 35% | Â | Â |
N1 | 16 | 0% | 13 | 65% | Â | Â |
N2 | 2 | 10% | 0 | 0% | Â | Â |
N3 | 0 | 80% | 0 | 0% | Â | Â |
Tumor | Â | Â | Â | Â | Â | Â |
T1 | 0 | 0% | 0 | 0% | Â | Â |
T2 | 0 | 0% | 6 | 30% | Â | Â |
T3 | 0 | 0% | 13 | 65% | Â | Â |
T4 | 20 | 100% | 1 | 5% | Â | Â |
Metastasis | Â | Â | Â | Â | Â | Â |
M0 | 14 | 70% | 4 | 20% | Â | Â |
M1 | 0 | 0% | 2 | 10% | Â | Â |
Unknown | 6 | 30% | 14 | 70% | Â | Â |
ER status | Â | Â | Â | Â | Â | Â |
Positive | 3 | 15% | 11 | 55% | Â | Â |
Negative | 17 | 85% | 9 | 45% | Â | Â |
PR status | Â | Â | Â | Â | Â | Â |
Positive | 4 | 20% | 11 | 55% | Â | Â |
Negative | 16 | 80% | 9 | 45% | Â | Â |
HER2 status | Â | Â | Â | Â | Â | Â |
Positive | 13 | 65% | 13 | 65% | Â | Â |
Negative | 7 | 35% | 7 | 35% | Â | Â |